SCHEMBL20176101

SCHEMBL20176101

CC(O)(C(=O)CCl)c1ccc2ccccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.44
CASR P41180 1/20 0.41
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
KCNH2 Q12809 1/20 0.40
KIF11 P52732 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
KDM4E B2RXH2 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
MEN1 O00255 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29226433 0.81 PTPN1 (0.47) PTPN1CASRCYP3A4CYP2D6SLC6A2
SCHEMBL7861321 0.81 PTPN1 (0.47) PTPN1CASRCYP3A4CYP2D6SLC6A2
SCHEMBL29941124 0.81 PTPN1 (0.47) PTPN1CASRCYP3A4CYP2D6SLC6A2
SCHEMBL20176100 0.75 NPC1 (0.44) KIF11SMN1; SMN2HPGDMEN1ALDH1A1
SCHEMBL20176099 0.75 KMT2A (0.52) SMN1; SMN2MEN1ALDH1A1KMT2ACYP1A2
SCHEMBL548731 0.74 PTPN1 (0.50) PTPN1CASRCYP3A4CYP2D6SLC6A2
SCHEMBL7132144 0.74 CASR (0.58) PTPN1CASRCYP3A4CYP2D6SLC6A2
SCHEMBL20176103 0.72 ALDH1A1 (0.48) CYP3A4KIF11SMN1; SMN2HPGDMEN1
SCHEMBL20176102 0.72 ATM (0.44) KDM4ESMN1; SMN2HPGDMEN1KMT2A
SCHEMBL9719820 0.72 PTPN1 (0.49) PTPN1CASRCYP3A4CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof EAST CHINA NORMAL UNIVERSITY (CN) 2019-10-22 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF EAST CHINA NORMAL UNIVERSITY (CN) 2018-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180141964-A1 FUNCTIONALIZED CYANOSILANE AND SYNTHESIS METHOD AND USE THEREOF NCLN, PNN, MB PTPN1 4263/4885CASR 3256/4885CYP3A4 1648/4885
US-10450331-B2 Functionalized cyanosilane and synthesis method and use thereof NCLN, PNN, MB PTPN1 4263/4885CASR 3256/4885CYP3A4 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.